Cargando…
A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
Inflammation plays a pivotal role in the initiation and progression of atherosclerosis (ATH). Due to their potent immunomodulatory properties, mesenchymal stromal cells (MSCs) are evaluated as therapeutic tools in ATH and other chronic inflammatory disorders. Aging reduces MSCs immunopotency potenti...
Autores principales: | Kizilay Mancini, Özge, Lora, Maximilien, Shum‐Tim, Dominique, Nadeau, Stephanie, Rodier, Francis, Colmegna, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442842/ https://www.ncbi.nlm.nih.gov/pubmed/28194905 http://dx.doi.org/10.1002/sctm.16-0221 |
Ejemplares similares
-
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Kizilay Mancini, Ozge, et al.
Publicado: (2015) -
Erratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Mancini, Ozge Kizilay, et al.
Publicado: (2017) -
CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
por: Psaroudis, Rose Triantafillia, et al.
Publicado: (2022) -
Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use
por: Torrents, Sílvia, et al.
Publicado: (2023) -
Increased IL-6 secretion by aged human mesenchymal stromal cells disrupts hematopoietic stem and progenitor cells' homeostasis
por: O'Hagan-Wong, Kelsey, et al.
Publicado: (2016)